Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon

High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the outcome of acral melanoma patients treated with IFN-α-2b. Pretreatment baseline parameters and clinical data were assessed in 22...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiayi, Wu, Xiaowen, Yu, Huan, Li, Siming, Mao, LiLi, Chi, Zhihong, Si, Lu, Sheng, Xinan, Cui, Chuanliang, Dai, Jie, Ma, Meng, Tang, Huan, Xu, Tianxiao, Yan, Junya, Kong, Yan, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510521/
https://www.ncbi.nlm.nih.gov/pubmed/28710916
http://dx.doi.org/10.1016/j.tranon.2017.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510521/
https://www.ncbi.nlm.nih.gov/pubmed/28710916
http://dx.doi.org/10.1016/j.tranon.2017.06.004

Ejemplares similares